Even the Scientist Who Discovered the SRY Gene Says This Is Wrong — So Why Is the IOC Pushing It?

Let me start with what is likely to happen in the next few months. Caster Semenya's class-action lawsuit will almost certainly be officially filed within the second half of 2026. She has already publicly called on athletes to "come together as one," and influential figures like Dutee Chand have signaled their willingness to join. The Court of Arbitration for Sport (CAS) will serve as the first battleground, and Semenya brings extensive experience from that arena. Although she lost the 2019 case against World Athletics, one of the three arbitrators explicitly stated in a dissenting opinion that "this regulation is discriminatory." This time around, the UN Human Rights Council's February 2026 statement could prove to be a game-changing legal weapon. When a human rights body has clearly declared that "forced genetic testing violates human rights," there is real room for CAS to reach a different conclusion than it did before.

Significant friction is also expected throughout the LA 2028 preparation process. LGBTQ+ organizations in the United States are already pushing back forcefully against the IOC policy, and Olympic sponsors face the excruciating task of not alienating either side of this debate. Global sponsors like Nike and Coca-Cola have championed diversity and inclusion as core brand values for years, and they will now have to grapple with the contradiction between the IOC's new policy and their own carefully cultivated brand identities. As sponsorship renegotiations kick off in the second half of 2026, this issue has the potential to escalate from a sports policy dispute into a multi-billion-dollar business concern that reverberates through boardrooms worldwide.

Looking at the medium-term window of one to two years, the outcomes of legal battles will be the decisive factor in determining the direction of sports policy globally. The European Court of Human Rights (ECHR) already recognized a human rights violation by the Swiss government in its 2023 Chamber ruling on a Semenya-related case, voting 4-3 that Articles 14 and 8 had been violated. The 2025 Grand Chamber final ruling then found a 15-2 violation of Article 6 (the right to a fair trial), though it declined jurisdiction on Articles 8 and 14. Critically, four dissenting judges issued a powerful opinion — Judge Simackova pointed out that Semenya faces intersectional discrimination as "a woman, Black, and from the Global South." If the current SRY gene testing policy reaches the ECHR, European Olympic committees could find themselves legally unable to enforce the test on their athletes. That would create a head-on collision between IOC policy and European human rights law, trapping the IOC in a dilemma: either modify the policy or carve out exemptions for European athletes. And once universal application breaks down, the policy's legitimacy crumbles with it.

The trajectory of World Athletics also deserves close attention. Even before the IOC's announcement, World Athletics had already introduced mandatory SRY gene testing, drawing fierce pushback from the scientific community. An academic paper published on idrottsforum.org branded the decision a "regression, not progress," and Professor Sinclair from the Murdoch Children's Research Institute issued an open letter in opposition. As these scientific criticisms continue to pile up, there is a realistic possibility that the IOC will modify the policy within 18 to 24 months, framing the revision as a "scientific advisory committee review." The most likely outcome would not be a complete abandonment of SRY testing, but rather the introduction of supplementary evaluation procedures following a positive result — testosterone level assessments, androgen sensitivity testing, and individualized medical review panels.

The International Commission of Jurists (ICJ) published a joint statement in March 2026 arguing that genetic sex testing in sport conflicts with (1) the IOC's own existing guidelines, (2) domestic and international human rights law, and (3) regulations governing genetic testing and the use of genetic information. The European Society of Human Genetics (ESHG) issued an official statement calling the SRY test "a proxy and not definitive," recommending that exceptions should be considered for both XY individuals with more feminine phenotypes and XX individuals with more masculine phenotypes. These institutional voices carry enormous weight in legal proceedings and regulatory discussions, and they are uniformly skeptical of the IOC's approach.

In the long term — three to five years out — the gender binary in sports itself will face fundamental challenges. The current Olympic framework divides competitions into male and female categories, but the scientific consensus that biological sex is not strictly binary continues to strengthen. Intersex conditions occur in approximately 1.7 percent of the population, which is about the same prevalence as red hair. By the 2030s, alternative frameworks — such as "hormone-profile-based categories" or "physical-advantage-based classifications" analogous to weight classes in boxing or wrestling — will be seriously discussed at least within academic and policy circles. Actual implementation would take considerably longer, but the IOC controversy will serve as the catalyst that launches these conversations into the mainstream.

Let me walk through three scenarios. The most optimistic case — call it the bull case — involves Semenya winning at CAS or the ECHR, which forces the IOC to abandon standalone SRY testing before 2028 and transition to a more sophisticated multi-biomarker system. In this scenario, LA 2028 gets remembered as a "triumph of sports science" — the Games where evidence defeated ideology. I put the probability of this scenario at roughly 25 percent.

The base case — and the most likely path — involves the IOC maintaining SRY testing while legal proceedings grind forward, but announcing a modified policy sometime in 2027 that bolsters the post-positive-result evaluation process. Think of it as the IOC trying to have it both ways: keeping the test in name while softening its impact enough to survive legal challenges. Additional medical evaluation for athletes who test positive, including testosterone level assessments, androgen sensitivity panels, and individualized review by an expert medical committee, would be added. This is precisely what the ESHG has recommended — that unexpected results should trigger supportive medical and psychological pathways rather than automatic disqualification. The probability here sits at approximately 50 percent.

The bear case — the most pessimistic scenario — involves sustained pressure from the Trump administration, with the IOC prioritizing its relationship with the US government as the LA 2028 host nation and the billions in hosting revenue at stake. Under this scenario, the policy is rigidly enforced, multiple intersex athletes from developing nations are disqualified in the months leading up to the Games, and a coalition of nations declares an Olympic boycott in solidarity. Athletes like Semenya become symbols of institutional injustice in a way that transcends sport. If the bear case materializes, LA 2028 would become the most controversial Games in Olympic history, potentially rivaling the political boycotts of Moscow 1980 and Los Angeles 1984. The probability is roughly 25 percent, but the consequences would be devastating and long-lasting.

There is one additional cascading effect that cannot be ignored. The IOC's decision creates a domino effect across every other international sports governing body. If FIFA, FIBA, the ITF, and others follow the IOC's lead and adopt similar policies, women's sports worldwide will regress to an era of genetic testing — a return to practices that were abandoned precisely because they did not work. Conversely, if the IOC reverses course after a legal defeat, every organization that copied the policy will have to retreat as well. The IOC is not just one sports body among many; it sits at the apex of global sports governance. That means this policy's ripple effects extend far beyond the Olympic arena. Whether this policy survives in some form by the time the LA 2028 opening ceremony takes place, or whether it has already been consigned to the dustbin of history, depends entirely on the legal and political battles of the next two years.

The secondary and tertiary effects on related industries are also substantial. The genetic testing industry has gained a new market in sports, but the very public debate about the test's limitations could simultaneously raise trust issues for genetic testing across all its applications — from healthcare to ancestry to forensics. Sports broadcasters will need to develop new editorial guidelines for handling controversies about athletes' genetic eligibility during live competition coverage, a situation for which there is no modern precedent. And perhaps most consequentially, this controversy will shape sports-related legislation in countries around the world. Multiple US states have already passed laws targeting transgender athletes, and the IOC's decision effectively provides international legitimacy to that domestic legislation. If the IOC policy is later invalidated by courts, the legal foundation supporting those state-level laws weakens in turn.

There is also a deeply personal dimension to this story that policy discussions tend to flatten into abstraction. Maria Jose Martinez-Patino, the Spanish hurdler who was flagged in 1985, described the experience in her own words: "I lost my friends, my fiance, my hopes." Ewa Klobukowska, the Polish sprinter stripped of her medals in 1967, had her medals taken despite having typical female reproductive anatomy — she later gave birth, proving conclusively that the test that destroyed her career was wrong. These are not hypothetical harms. They are documented, lived realities of what happens when blunt genetic instruments are applied to the infinitely complex reality of human biology. The athletes who will be caught by the revived SRY test will overwhelmingly be women from countries with fewer resources to challenge the results — women from Africa, South Asia, and South America who lack the legal and financial infrastructure to fight back the way Semenya has.

The IOC conducted an 18-month policy review from September 2024 to March 2026, convening a working group of experts from five continents spanning sports science, endocrinology, transgender medicine, ethics, and law. This is not nothing — it represents a genuine institutional effort to ground the policy in expertise. But the question is whether the working group's conclusions were genuinely independent or whether the political endpoint was predetermined. Coventry's insistence that this was her priority "way before President Trump came into his second term" may be true, but it does not address the more uncomfortable question of whether the IOC's definition of "science-based" was shaped by the political environment in which the review took place.

The numbers tell a stark story. At the 1996 Atlanta Olympics, 8 out of 3,387 athletes tested positive — and all 8 were intersex women with no competitive advantage. At the 1992 Barcelona Olympics, 12 tested positive: 1 false positive, 6 cases of incorrect gene identification, and 5 with DSD conditions. In 126 years of Olympic history, exactly one transgender woman — Laurel Hubbard — has ever competed, and she did not medal. Transgender athletes represent fewer than 10 out of 510,000 NCAA athletes, a rate of 0.002 percent. These are the numbers that supposedly justify reviving a test that has already been tried, found wanting, and discarded.

The International Commission of Jurists (ICJ) and multiple legal scholars have pointed out that this policy may violate the Council of Europe's Convention on Human Rights and Biomedicine, which restricts genetic testing to health-related purposes with informed consent. The Bioethics Convention explicitly states that genetic tests should not be performed for non-health purposes, and sport eligibility screening falls squarely outside that boundary. If this legal argument gains traction in European courts, the entire enforcement architecture of the IOC policy could be invalidated for athletes under European jurisdiction — which includes a substantial portion of Olympic competitors.

The question every sports fan, policymaker, and athlete should be asking is deceptively simple: if this test failed in the 1990s with these exact results, what has changed that would make it succeed now? The science has not changed — if anything, our understanding of sex biology has grown more nuanced, not less, making a binary test even more inappropriate than it was 30 years ago. The athletic landscape has not changed — the supposed epidemic of men infiltrating women's sports remains a phantom with zero documented cases. What has changed is the political climate, and that may be the most damning indictment of all. A policy that cannot justify itself on scientific or practical grounds but aligns perfectly with the political demands of the moment is not science — it is politics wearing a lab coat.